Publications by authors named "Vihang Vivek Ghalsasi"
Article Synopsis
- Rare diseases, or orphan diseases, are rare conditions with limited occurrence, making the development of treatments (orphan drugs) difficult due to scarce resources and challenges in clinical trials.
- Advances in genomic technologies and regulatory frameworks have led to some successful orphan drug approvals, particularly in the U.S., which has improved the landscape for these drugs.
- In India, despite recent policy changes that aim to improve the rare disease ecosystem, there is still a lack of clear guidelines for orphan drug development, necessitating collaboration among government, industries, and patient advocates to enhance the process.
Metabolomics is the study of metabolites present in a living system. It is a rapidly growing field aimed at discovering novel compounds, studying biological processes, diagnosing diseases, and ensuring the quality of food products. Recently, the analysis of natural samples has become important to explore novel bioactive compounds and to study how environment and genetics affect living systems.
View Article and Find Full Text PDF